Research Article| Volume 345, ISSUE 1-2, P164-167, October 15, 2014

Download started.


Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis — Data from a population-based registry



      The clinical spectrum of amyotrophic lateral sclerosis (ALS) is characterized by a considerable variation. Different phenotypes have been described by previous studies. We assessed clinical variability and prognostic relevance of these phenotypes in a prospective, population-based cohort of ALS patients in Rhineland-Palatinate, Germany.


      Incident ALS cases, diagnosed between October 2009 and September 2012, were prospectively enrolled and classified according to established ALS phenotype classification (bulbar, classic, flail arm, flail leg, pyramidal, respiratory). Survival probability was described using Kaplan–Meier method. Moreover, the influence of an additional frontotemporal dementia (FTD) was analysed.


      Phenotypes of all 200 patients were determined. Bulbar and classic phenotypes accounted for 75% of all cases. Deterioration of functional impairment during disease progression was lowest in flail leg and pyramidal variants, and most pronounced in bulbar and classic phenotypes. A poor survival prognosis was observed for bulbar, classic or respiratory phenotypes. Patients with an additional FTD showed an even worse outcome.


      Results suggest that ALS is a heterogeneous disease, as ALS phenotypes differ in disease progression and survival time. Patients classified as suffering from bulbar, classic and respiratory ALS, as well as those with an additional FTD, show a marked reduction of survival time.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ravits J.
        • La Spada A.R.
        ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.
        Neurology. 2009; 73: 805-811
        • Ravits J.
        • Paul P.
        • Jorg C.
        Focality of upper and lower motor neuron degeneration at the clinical onset of ALS.
        Neurology. 2007; 68: 1571-1575
        • Chio A.
        • Calvo A.
        • Moglia C.
        • Mazzini L.
        • Mora G.
        PARALS study group. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.
        J Neurol Neurosurg Psychiatry. 2011; 82: 740-746
        • Turner M.R.
        • Hardiman O.
        • Benatar M.
        • Brooks B.R.
        • Chio A.
        • de Carvalho M.
        • et al.
        Controversies and priorities in amyotrophic lateral sclerosis.
        Lancet Neurol. 2013; 12: 310-322
        • Wolf J.
        • Wöhrle J.C.
        • Palm F.
        • Nix W.A.
        • Maschke M.
        • Safer A.
        • et al.
        Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.
        Amyotroph Lat Scler Frontotemp Degeneration. 2014; 15: 269-274
        • Ross M.A.
        • Miller R.G.
        • Berchert L.
        • Parry G.
        • Barohn R.J.
        • Armon C.
        • et al.
        Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria.
        Neurology. 1998; 50: 768-772
        • The A.L.S.
        CNTF treatment study (ACTS) phase I–II study group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis.
        Arch Neurol. 1996; 53: 141-147
        • Kiernan M.C.
        • Vucic S.
        • Cheah B.J.
        • Zurner M.R.
        • Eisen A.
        • Hardiman O.
        • et al.
        Amyotrophic lareral sclerosis.
        Lancet. 2011; 377: 942-955
        • Wijesekera L.C.
        • Mathers S.
        • Talman P.
        • Galtrey C.
        • Parkinson M.H.
        • Ganesalingam J.
        • et al.
        Natural history and clinical features of the flail arm and flail leg ALS variants.
        Neurology. 2009; 72: 1087-1094
        • Gordon P.H.
        • Cheng B.
        • Katz I.B.
        • Mitsumoto H.
        • Rowland L.P.
        Clinical features that distinguish PUMN, upper motor neuron-dominant ALS, and typical ALS.
        Neurology. 2009; 72: 1948-1952
        • Shoesmith C.L.
        • Findlater K.
        • Rowe A.
        • Strong M.J.
        Prognosis of amyotrophic lateral sclerosis with respiratory onset.
        J Neurol Neurosurg Psychiatry. 2007; 78: 629-631
        • Kimura F.
        • Fujimura C.
        • Ishida S.
        • Nakajima H.
        • Furutama D.
        • Uehara H.
        • et al.
        Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS.
        Neurology. 2006; 66: 265-267
        • Kollewe K.
        • Mauss U.
        • Krampfl K.
        • Petri S.
        • Dengler R.
        • Mohammadi B.
        ALSFRS-R score and its ratio: a useful predictor for ALS progression.
        J Neurol Sci. 2008; 275: 69-73
        • De Carvalho M.
        • Scotto M.
        • Lopes A.
        • Swash M.
        Quantitating progression in ALS.
        Neurology. 2005; 64: 1783-1785
        • Ganesalingam J.
        • Stahl D.
        • Wijesekera L.
        • Galtrey C.
        • Shaw C.E.
        • Leigh P.N.
        • et al.
        Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.
        PLoS One. 2009; 4: e7107
        • Elamin M.
        • Phukan J.
        • Bede P.
        • Jordan N.
        • Byrne S.
        • Pender N.
        • et al.
        Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.
        Neurology. 2011; 76: 1263-1269
        • Oh S.I.
        • Park A.
        • Kim H.J.
        • Oh K.W.
        • Choi H.
        • Kwon M.J.
        • et al.
        Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.
        PLoS One. 2014; 9: e87163
        • Merrilees J.
        • Klapper J.
        • Murphy J.
        • Lomen-Hoerth C.
        • Miller B.L.
        Cognitive and behavioural challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis.
        Amyotroph Lateral Scler. 2010; 11: 298-302
        • Chio A.
        • Logroscino G.
        • Hardiman O.
        • Swingler R.
        • Mitchell D.
        • Beghi E.
        • et al.
        Prognostic factors in ALS: a critical review.
        Amyotroph Lateral Scler. 2009; 10: 310-323